| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $457.8M | +7.6% |
| R&D Expense | $185.2M | +107.2% |
| SG&A Expense | $47.4M | -22.6% |
| Operating Income | $150.5M | +111.4% |
| Interest Expense | $29.5M | +16.9% |
| Pre-tax Income | $117.6M | +104.3% |
| Income Tax | $25.5M | +65.9% |
| Net Income | $93.7M | +69.4% |
| EPS (Basic) | $3.11 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $693.5M | -1.8% |
| Short-term Investments | $508.3M | +116.0% |
| Accounts Receivable | $53.2M | +70.9% |
| Current Assets | $1.34B | +28.0% |
| Total Assets | $1.90B | +16.7% |
| Current Liabilities | $271.3M | -27.0% |
| Long-term Debt | $607.1M | +43.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $286.0M | +119.4% |
| Capital Expenditures | $3.2M | +25.7% |
| Investing Cash Flow | -$314.7M | -275.2% |
| Financing Cash Flow | $18.6M | +125.0% |
| Free Cash Flow | $282.9M | +121.2% |
| +72.8% |
| EPS (Diluted) | $3.07 | +73.4% |
| Total Liabilities |
| $1.17B |
| +33.6% |
| Stockholders' Equity | $724.9M | -2.7% |